Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 14, 2022; 10(2): 631-642
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.631
Malignant solitary fibrous tumor in the central nervous system treated with surgery, radiotherapy and anlotinib: A case report
Dong-Yong Zhang, Lan Su, Yi-Wei Wang
Dong-Yong Zhang, Department of Neurosurgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Lan Su, Department of Genetron Health, Genetron Health, Beijing 110024, China
Yi-Wei Wang, Department of Anatomy, Shenyang Medical College, Shenyang 110034, Liaoning Province, China
Author contributions: Zhang DY drafted the manuscript and prepared the figures; Su L drafted the global landscape; Wang YW analyzed the immunohistochemical results and reviewed the manuscript; all authors read and approved the final manuscript.
Informed consent statement: This case was reported with consent from the patient’s parents. Informed consent for treatment was obtained from the patient’s parents.
Conflict-of-interest statement: The authors declare that they have no competing interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong-Yong Zhang, PhD, Doctor, Department of Neurosurgery, the First Affiliated Hospital of China Medical University, Heping District, Shenyang 110001, Liaoning Province, China. zhangdongyong@cmu.edu.cn
Received: May 3, 2021
Peer-review started: May 3, 2021
First decision: October 16, 2021
Revised: November 1, 2021
Accepted: December 7, 2021
Article in press: December 7, 2021
Published online: January 14, 2022
Processing time: 253 Days and 23.4 Hours
Core Tip

Core Tip: Solitary fibrous tumor (SFT) of the central nervous system is rare. There is no established standardized treatment regimen for malignant intracranial SFTs. This is the first reported case of SFT in the central nervous system treated with surgery, radiotherapy and anlotinib. This treatment regimen might be an effective treatment option for malignant intracranial SFT patients.